Is Alexion Pharmaceuticals (NASDAQ:ALXN) Stock A Good Investment?

With Soliris prediction through 2018, we explore whether Alexion Pharmaceuticals (NASDAQ:ALXN) is a good investment opportunity.

Posted in HADE Platform, Healthcare & Biotech, Members | Tagged , | Leave a comment

7 Laggards That Are Bargains In 2017: SHLD, GNC, CLDX, HBI, ALXN

Sears (SHLD), Noodles (NDLS), Celldex Therapeutics (CLDX), Hanesbrands (HBI), CPI Card (PMTS), GNC, & Alexion (ALXN) are laggards with turnaround potential.

Posted in Members, Portfolio Strategy, Timely Analysis | Tagged , , , , , , , , , , , , , | 1 Comment

Why Sarepta Therapeutics (SRPT) Stock Will Double Over Next 12-Months

Sarepta Therapeutics investors should not worry about the FDA or a slow launch for Exondys 51; investors should expect SRPT stock soar short-term.

Posted in BNL Reports, Healthcare & Biotech | Tagged , , , , , , , | Leave a comment

These 10 Biotech Stocks Will Be M&A Targets

These biotech stocks are all prime M&A targets: Gilead Sciences Inc, Alexion Pharmaceuticals, Inc., ACADIA Pharmaceuticals Inc., Sarepta Therapeutics Inc, Intercept Pharmaceuticals Inc, Juno Therapeutics Inc, Kite Pharma Inc, Regeneron Pharmaceuticals Inc, Biogen Idec, and Celldex Therapeutics, Inc.

Posted in Healthcare & Biotech, Mergers & Acquisitions | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Why Hillary Clinton Is Bad News For Gilead Stock & Biotechnology (NASDAQ:GILD)

Gilead stock is one of many in biotechnology that could face Hillary Clinton’s wrath when and if she is elected President.

Posted in Healthcare & Biotech, Politics | Tagged , , , , , , , , , , , , , , , , , | Leave a comment